Table 2.

Patient disposition

	SOF SMV (n=667)	SOF SMV RBV (n=169)	Total (n=836)
Patient disposition during treatment, n (%)
Completed therapy	648 (97.2)	163 (96.4)	811 (97.0)
Discontinued therapy early	19 (2.8)	6 (3.6)	25 (3.0)
Adverse event	13 (1.9)	4 (2.4)	17 (2.0)
Lack of efficacy	1 (0.1)	0 (0.0)	1 (0.1)
Withdrawal by subject	1 (0.1)	0 (0.0)	1 (0.1)
Loss to follow up during treatment	1 (0.1)	1 (0.6)	2 (0.2)
Other	3 (0.4)	1 (0.6)	4 (0.5)
Completed SVR 12 Follow-up	639 (96)	163 (98)	802 (96)
Lost to post treatment follow-up*	21(3)	9 (5)	30 (4)
HCV RNA result not available**	28 (4)	6 (4)	34 (4)

^*Included in the “Completed SVR12 follow up”

^**HCV RNA result not yet available as of last follow-up appointment